financetom
Business
financetom
/
Business
/
Las Vegas Sands beats quarterly profit estimates on strong Singapore, Macau businesses
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Las Vegas Sands beats quarterly profit estimates on strong Singapore, Macau businesses
Oct 22, 2025 3:42 PM

(Reuters) -Las Vegas Sands ( LVS ) on Wednesday topped Wall Street expectations for third-quarter profit on strong demand from both its Singapore and Macau businesses, sending its shares up more than 6% after the bell.

The Nevada-based company - which operates integrated resorts and casinos, such as Marina Bay Sands in Singapore, and six properties in Macau, including The Venetian Macau - cited strong demand from its properties.

Las Vegas Sands ( LVS ) increased its annual dividend to $1.20 per share, and increased its stock repurchase to $2 billion.

The company posted adjusted quarterly profit of 78 cents per share. Analysts, on average, were expecting a profit of 60 cents apiece, according to data compiled by LSEG.

Total revenue from Macau operations rose 7.6% to $1.91 billion year over year, compared with consensus estimates of $1.84 billion.

Its total revenue from Singapore operations rose 56.3% to $1.44 billion from last year, above analysts' expectations of $1.14 billion.

The company's total quarterly revenue rose to $3.33 billion from a year earlier. Analysts, on average, expected revenue of $3.03 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ARS Pharmaceuticals Files Response to FDA Complete Response Letter For Neffy
ARS Pharmaceuticals Files Response to FDA Complete Response Letter For Neffy
Apr 3, 2024
10:54 AM EDT, 04/03/2024 (MT Newswires) -- ARS Pharmaceuticals ( SPRY ) said Wednesday that it has submitted a response to the US Food and Drug Administration for its new drug application for neffy for the treatment of Type I allergic reactions including anaphylaxis. The submission follows the receipt of a complete response letter from the regulator in September that...
Stellantis Q1 Total Vehicle Sales Drop 10% Year-Over-Year; Plug-In Hybrid Sales Surge 82%
Stellantis Q1 Total Vehicle Sales Drop 10% Year-Over-Year; Plug-In Hybrid Sales Surge 82%
Apr 3, 2024
11:00 AM EDT, 04/03/2024 (MT Newswires) -- Stellantis' ( STLA ) FCA US reported Q1 total sales Wednesday of 332,540 vehicles, down 10% from a year earlier. Total sales of plug-in hybrid electric vehicles increased 82% year over year in Q1, according to the company. The Jeep and Chrysler brands saw Q1 vehicle sales grow 2% and 9% year over...
Update: Calibre's Valentine Gold Mine 2024 Exploration Program Underway; National Bank Ascribes Neutral Bias
Update: Calibre's Valentine Gold Mine 2024 Exploration Program Underway; National Bank Ascribes Neutral Bias
Apr 3, 2024
11:00 AM EDT, 04/03/2024 (MT Newswires) -- Calibre Mining ( CXBMF ) on Wednesday said its 2024 exploration program at the Valentine gold mine in Newfoundland and Labrador is underway. According to a statement, the property hosts five gold deposits with measured and indicated resources of 4.0 million ounces and inferred resources of 1.1 million ounces. Drilling is underway at...
Identiv to Sell Certain Assets to Vitaprotech for $145 Million in Cash; Shares Fall
Identiv to Sell Certain Assets to Vitaprotech for $145 Million in Cash; Shares Fall
Apr 3, 2024
10:59 AM EDT, 04/03/2024 (MT Newswires) -- Identiv ( INVE ) said Wednesday it has agreed to sell its physical security, access card, and identity reader operations and assets to Vitaprotech for $145 million in cash. The company expects the deal to close in Q3, subject to shareholder approval and other conditions. Upon the deal's closing, certain senior executives will...
Copyright 2023-2026 - www.financetom.com All Rights Reserved